Skip to content
★ Sign in to follow
Total declarations
1
Company
1
▲ Purchases (1 ops.)
€2,561
▼ Sales (0 ops.)
—

Latest filing published 21 Aug 2017 for Xenon Pharmaceuticals Inc., €2,561.

Filing timeline

BuySale
Raymond Winquist

Insider track record

Disclosed buys
1
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
1

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Raymond Winquist: trading record in brief

One trade, one date: on 21 August 2017, Raymond Winquist disclosed an open-market purchase of €2,561 in Xenon Pharmaceuticals Inc. No broader history exists yet. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Raymond Winquist

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations1 total
  • ▲
    Head, Translational ResearchExecutivesXenon Pharmaceuticals Inc.
    3,000 USD37SEC
    1,000 shares@ US$3.00100.0% of flowCommon SharesSEC:0001171843-17-005193:0
    Canonical exit: 16 Nov 2017 (T+90)

1 of 1 declaration